Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,682,200
+$3,716,855 QoQ
Shares Held
820,000
+370.6% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
3.38%
of 13F equity value
Holder Rank
#39
of 216 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ishara Investments LP holds $128,591,353 across 40 Biotechnology names. ANNX ranks #11 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
410,000 | $10,373,000 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
143,500 | $8,211,070 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
22,550 | $7,549,514 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
205,000 | $6,844,950 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
164,000 | $6,086,040 | |
| 6 | INSM |
INSMED Inc
|
51,250 | $5,464,275 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
123,000 | $5,410,770 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
143,500 | $5,369,770 |
All Filings in ANNX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,682,200 | 820,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $965,345 | 174,250 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,765,000 | 750,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||